
@Article{,
AUTHOR = {Martin Miner, Matt T. Rosenberg, Jack Barkin},
TITLE = {Erectile dysfunction in primary care: a focus on cardiometabolic risk evaluation and stratification for future cardiovascular events},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {21},
YEAR = {2014},
NUMBER = {Suppl.3},
PAGES = {25--38},
URL = {http://www.techscience.com/CJU/v21nSuppl.3/63002},
ISSN = {1488-5581},
ABSTRACT = {An association between erectile dysfunction (ED) and 
cardiovascular disease has long been recognized, and 
studies suggest that ED is an independent marker of 
cardiovascular disease risk and even further, a marker 
for the burden of both obstructive and non-obstructive 
coronary artery disease. Therefore, the primary care 
physician (PCP) must assess the presence or absence of 
ED in every man > 39 years of age, especially if that man 
is asymptomatic of signs and symptoms of coronary artery 
disease. Assessment and management of ED may help 
identify and reduce the risk of future cardiovascular events, 
particularly in younger middle-aged men. The initial ED 
evaluation should distinguish between predominantly 
vasculogenic ED and ED of other etiologies. For men 
believed to have predominantly vasculogenic ED, we 
recommend that initial cardiovascular risk stratification 
be based on the Framingham Risk Score. Management 
of men with ED who are at low risk for cardiovascular 
disease should focus on risk factor control; men at high 
risk, including those with cardiovascular symptoms, 
should be referred to a cardiologist. Intermediate risk men 
should undergo noninvasive evaluation for subclinical 
atherosclerosis. A growing body of evidence supports the 
use of selected prognostic markers to further understand 
cardiovascular risk in men with ED, particularly CT 
calcium scoring. In conclusion, we support cardiovascular 
risk stratification and risk factor management in all men 
with vasculogenic ED.},
DOI = {}
}



